PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.98%
Revenue growth above 1.5x ADI's 3.99%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
13.85%
Gross profit growth above 1.5x ADI's 3.24%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
55.96%
EBIT growth above 1.5x ADI's 7.45%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
34.61%
Operating income growth above 1.5x ADI's 7.45%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
52.80%
Net income growth above 1.5x ADI's 9.45%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
58.33%
EPS growth above 1.5x ADI's 10.34%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
58.33%
Diluted EPS growth above 1.5x ADI's 10.71%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-4.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-3.80%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.68%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
58.13%
OCF growth 1.25-1.5x ADI's 49.91%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
131.71%
FCF growth above 1.5x ADI's 65.15%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-8.26%
Negative 10Y revenue/share CAGR while ADI stands at 234.95%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
19.49%
Positive 5Y CAGR while ADI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
74.31%
3Y revenue/share CAGR above 1.5x ADI's 43.64%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
93.48%
10Y OCF/share CAGR under 50% of ADI's 477.69%. Michael Burry would worry about a persistent underperformance in cash creation.
35.53%
5Y OCF/share CAGR above 1.5x ADI's 8.25%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
148.63%
3Y OCF/share CAGR under 50% of ADI's 593.35%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
107.17%
Below 50% of ADI's 422.86%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-49.18%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
669.14%
3Y net income/share CAGR similar to ADI's 701.71%. Walter Schloss would attribute it to shared growth factors or demand patterns.
195.47%
Below 50% of ADI's 717.95%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-5.11%
Negative 5Y equity/share growth while ADI is at 89.37%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
17.24%
3Y equity/share CAGR at 50-75% of ADI's 25.63%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
63.48%
Dividend/share CAGR of 63.48% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
26.48%
Dividend/share CAGR of 26.48% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
9.16%
3Y dividend/share CAGR of 9.16% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
12.15%
Our AR growth while ADI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-3.45%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-3.72%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
0.31%
Under 50% of ADI's 0.81%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-3.22%
We’re deleveraging while ADI stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-0.40%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-1.45%
We cut SG&A while ADI invests at 2.97%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.